• Nenhum resultado encontrado

[PDF] Top 20 The Current State of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer

Has 10000 "The Current State of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer" found on our website. Below are the top 20 most common "The Current State of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer".

The Current State of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer

The Current State of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer

... outcomes of patients (N=317) treated with radical cystectomy and NAC (combination group) were compared with radical cystectomy alone (cystectomy ...81% of the patients in the combination and ... See full document

6

Int. braz j urol.  vol.36 número1

Int. braz j urol. vol.36 número1

... to neoadjuvant cisplatin-based ...survival. The median follow-up was 86 mo and all patients were followed for more than 5 ...54% of them having an intact functioning bladder. The number ... See full document

2

Association of Pretreatment Anemia with Pathological Response and Survival of Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Population-Based Study.

Association of Pretreatment Anemia with Pathological Response and Survival of Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Population-Based Study.

... total of 655 consecutive patients with operable or locally advanced breast cancer who received NCT at Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College ... See full document

13

Int. braz j urol.  vol.37 número5

Int. braz j urol. vol.37 número5

... for the management of patients with bladder cancer encompass strategies that minimize morbidity and improve ...In the current study, the authors sought to character- ize ... See full document

1

Risk prediction scores for recurrence and progression of non-muscle invasive bladder cancer: an international validation in primary tumours.

Risk prediction scores for recurrence and progression of non-muscle invasive bladder cancer: an international validation in primary tumours.

... Remarkably, the CUETO score was specifically developed for patients treated with BCG, but discriminated better in the overall population than in the selected BCG ...patients, of over 50% at ... See full document

7

Int. braz j urol.  vol.38 número4

Int. braz j urol. vol.38 número4

... as the most effective treatment for patients with high-risk ...tion of chemotherapy before intravesical BCG in- stillation in patients at an intermediate or high risk of tumor progression ... See full document

6

Int. braz j urol.  vol.37 número5

Int. braz j urol. vol.37 número5

... and the related calculator at ...estimate the risk of recurrence and progression in patients with non-muscle invasive bladder cancer ...(NMIBC). The underlying ... See full document

2

Neoadjuvant Radiotherapy and Hormonotherapy in Locally Advanced Breast Cancer: State of the Art

Neoadjuvant Radiotherapy and Hormonotherapy in Locally Advanced Breast Cancer: State of the Art

... not the use of concomitant radiotherapy and neoadjuvant hormone therapy instead to neoad- juvante chemotherapy in post menopausal patients diagnosed with locally advanced breast cancer ... See full document

5

Int. braz j urol.  vol.36 número1

Int. braz j urol. vol.36 número1

... to neoadjuvant cisplatin-based ...survival. The median follow-up was 86 mo and all patients were followed for more than 5 ...54% of them having an intact functioning bladder. The number ... See full document

2

ErbB2 and NFκB overexpression as predictors of chemoradiation resistance and putative targets to overcome resistance in muscle-invasive bladder cancer.

ErbB2 and NFκB overexpression as predictors of chemoradiation resistance and putative targets to overcome resistance in muscle-invasive bladder cancer.

... The current study indicates that both erbB2 and NFkB are putative targets for treatments to overcome CRT resistance in ...Among the small molecules currently being investigated in clinical studies, ... See full document

5

Int. braz j urol.  vol.36 número2

Int. braz j urol. vol.36 número2

... half of the patients treated with RC without neoadjuvant chemotherapy for clini- cal T1G3 UCB are upstaged to muscle-invasive ...support the inadequacy of clinical ... See full document

2

Int. braz j urol.  vol.33 número5

Int. braz j urol. vol.33 número5

... out of 20 assessable patients ...out of 21 patients (43%) relapsed and four (19%) died due to disease ...survival of 36 months (CI 95%: ...to chemotherapy. Conclusions: The combination ... See full document

9

Leitlinie Blasenkarzinom

Leitlinie Blasenkarzinom

... instillation of chemotherapy decreases the risk of recurrence in patients with stage TaT1 bladder cancer: a meta-analysis of published results of randomized ... See full document

12

The prognostic value of BRCA1 mRNA expression levels following neoadjuvant chemotherapy in breast cancer.

The prognostic value of BRCA1 mRNA expression levels following neoadjuvant chemotherapy in breast cancer.

... for the 45 patients in whom BRCA1 mRNA levels were not ...to the decision of the Breast Cancer Committee of our institution and were treated with four cycles of ...After ... See full document

9

Noninvasive assessment of response to neoadjuvant chemotherapy in osteosarcoma of long bones with diffusion-weighted imaging: an initial in vivo study.

Noninvasive assessment of response to neoadjuvant chemotherapy in osteosarcoma of long bones with diffusion-weighted imaging: an initial in vivo study.

... [17,18]. The post- neoadjuvant chemotherapy ADC values were significantly higher than the pre- neoadjuvant chemotherapy values both in patients with good response and poor ... See full document

7

Int. braz j urol.  vol.39 número5

Int. braz j urol. vol.39 número5

... The main advantage of RC is the preven- tion of local symptoms such as recurrent hematu- ria, clot retention, upper urinary tract dilatation with renal impairment, and voiding symptoms such ... See full document

9

Int. braz j urol.  vol.34 número1

Int. braz j urol. vol.34 número1

... knowledge the outcomes of laparoscopic renal oncological surgery in patients with major aortic and/or inferior vena caval pathology are ...tumor. Of these patients 66 ...entities of the ... See full document

3

SOCIAL ECONOMY – A FORM OF INCLUSION AND OF ''REACTIVATING'' OF LABOR IN THE CONTEXT OF THE CURRENT CRISIS

SOCIAL ECONOMY – A FORM OF INCLUSION AND OF ''REACTIVATING'' OF LABOR IN THE CONTEXT OF THE CURRENT CRISIS

... essence of social economy is the inclusive function of the labor market through which the different forms of social economy that exist in the member states can play a role ... See full document

13

The application of optical measurements for the determination of accuracy of gear wheels casts manufactured in the RT/RP process

The application of optical measurements for the determination of accuracy of gear wheels casts manufactured in the RT/RP process

... discusses the possibilities of using optical measurements for defining the geometric accuracy of gear wheels casts manufactured in the rapid prototyping ...process. The tested ... See full document

4

Endoscopic gold fiducial marker placement into the bladder wall to optimize radiotherapy targeting for bladder-preserving management of muscle-invasive bladder cancer: feasibility and initial outcomes.

Endoscopic gold fiducial marker placement into the bladder wall to optimize radiotherapy targeting for bladder-preserving management of muscle-invasive bladder cancer: feasibility and initial outcomes.

... Two of 18 patients elected to undergo cystectomy before initiating ...chemo-radiotherapy. The remaining 16 patients (82 markers) completed chemo-radiation ...two of the 4 markers placed fell ... See full document

10

Show all 10000 documents...